Find below videos and webinars on myeloma. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
Ask the Expert Q&A | Living well with myeloma
Now Playing
Ask the Expert Q&A | Living well with myeloma
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds ...
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds patients' questions about living well with myeloma. This Q&A was organised by Myeloma Patients Europe (MPE) on the occasion of the Myeloma ...Awareness Month 2025.Show More
Now Playing
Webinar EYMPG | Importance of good nutrition and healthy diet for young myeloma patients
This webinar, organised by the MPE European Young Myeloma Patient ...
This webinar, organised by the MPE European Young Myeloma Patient Group (EYMPG), was given by Inês Almada Correia, Nutritionist specialising in Oncology and Autoimmunity, from Portugal.
Now Playing
MPE webinar | Disease and treatment specificities for young myeloma patients
Recording of the webinar "Disease and treatment specificities for ...
Recording of the webinar "Disease and treatment specificities for young myeloma patients" organised by the MPE’s European Young Myeloma Patients Group. The webinar was given by Prof. Dr. Michel Delforge, ...Clinical Head of Haematology at the University Hospital UZ Leuven, Belgium, and Professor of Medicine at the KU Leuven, on 9 July 2024.Show More
Now Playing
MPE Webinar | EHA 2024 myeloma highlights
Myeloma Patients Europe (MPE) hosted a webinar on 2nd July 2024 ...
Myeloma Patients Europe (MPE) hosted a webinar on 2nd July 2024 summarising the most important myeloma updates presented at the European Hematology Association (EHA) Annual Meeting held from 13 ...of June to 16, 2024, in Madrid, Spain. Prof. Dr. Hermann Einsele, Director of the Department of Internal Medicine II at the University Hospital Würzburg, Germany, presented key updates and insights followed by a 20-minute Q&A session.Show More
Now Playing
EHA 2024 | CAMMA 2 study
Doctor Kumar explains the CAMMA 2 study presented at the 2024 European ...
Doctor Kumar explains the CAMMA 2 study presented at the 2024 European Hematology Association annual congress in Madrid, Spain.
Now Playing
EHA 2024 | DREAMM 7 study
Doctor Dimopoulos explains the DREAMM-7 study presented at the 2024 ...
Doctor Dimopoulos explains the DREAMM-7 study presented at the 2024 European Hematology Association annual congress in Madrid, Spain.
Now Playing
EHA 2024 | The DREAMM-8 study
Doctor Dimopoulos explains the DREAMM-8 study, one of the ...
Doctor Dimopoulos explains the DREAMM-8 study, one of the late-breaking abstracts presented at the European Hematology Association annual congress in Madrid, Spain.
Now Playing
EHA2024 |The IMROZ study
Doctor Thierry Facon, professor of Haematology at Lille University ...
Doctor Thierry Facon, professor of Haematology at Lille University Hospital in France explains the results of the Phase 3 IMROZ study, comparing isatuximab, bortezomib, lenalidomide and dexamethasone, known as Isa-VRd, ...versus VRd for transplant-ineligible patients with newly diagnosed myeloma at the European Hematology Association annual congress in Madrid, Spain.Show More
Now Playing
Masterclass 2024 | Shared decision-making
Summary of the session "Shared decision-making: improving effective ...
Summary of the session "Shared decision-making: improving effective communication between the patient and the medical team", given by Silene Ten Seldam, Research Assistant at MPE, during the MPE Masterclass, in ...May 2024.Show More
Now Playing
Masterclass 2024 | Real World Evidence
Martine Elias, Executive Director, Myeloma Canada summarises the ...
Martine Elias, Executive Director, Myeloma Canada summarises the session " Real World Evidence (RWE)", held at the MPE Masterclass on May 2024.
Now Playing
Masterclass 2024 | Side effects and management of myeloma and AL amyloidosis treatments
Summary of the session "Side effects and management of myeloma and AL ...
Summary of the session "Side effects and management of myeloma and AL amyloidosis treatments" given by Dr. Charlotte Pawlyn, Haematologist and Clinician Scientist, Cancer Research UK, at the MPE Masterclass ...2024, held in Madrid, Spain.Show More
Now Playing
MPE Masterclass 2024 | Actualización de los tratamientos del mieloma y la amiloidosis AL
Resumen de la charla ofrecida por el Dr. Albert Oriol (ICO) durante la ...
Resumen de la charla ofrecida por el Dr. Albert Oriol (ICO) durante la Masterclass de Myeloma Patients Europe (MPE) que tuvo lugar en Madrid en mayo de 2024.
Now Playing
MPE Masterclass 2024 | Myeloma and AL amyloidosis treatment updates
Summary of the session on myeloma and AL amyloidosis treatment updates ...
Summary of the session on myeloma and AL amyloidosis treatment updates given by Dr Albert Oriol, Head of the Clinical Research Unit, Institut Català d’Oncologia (ICO), held in May 2024 ...in Madrid, SpainShow More
Now Playing
Myeloma and AL Amyloidosis European Clinical Trial Navigator
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an ...
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering ...multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search of clinical trials for these conditions and provide to patients, carers and advocates a patient-friendly tool not only to find clinical trials but also to know about their availability and location
for more information, head to our website: http://www.mpeurope.orgShow More
for more information, head to our website: http://www.mpeurope.orgShow More
Now Playing
The MPE clinical trial Navigator
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an ...
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering ...multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search of clinical trials for these conditions and provide to patients, carers and advocates a patient-friendly tool not only to find clinical trials but also to know about their availability and location
for more information, head to our website: http://www.mpeurope.orgShow More
for more information, head to our website: http://www.mpeurope.orgShow More
1
of 9